Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to assess the effect of missed doses of atomoxetine and OROS methylphenidate in ADHD patients who are stable on pharmacotherapy based on the patient’s daily behavior as assessed by the Daily Parent Report of Evening and Morning Behavior - Revised (DPREMB-R) scale from the parent perspective. The evaluation of the primary objective will be performed by comparing the DPREMB-R total score between days without missing doses (on-days) and days with missing doses (off-days) in patients receiving atomoxetine and in patients receiving OROS methylphenidate.
Critère d'inclusion
- Attention-Deficit/Hyperactivity Disorder (ADHD)